Rudolph Navari to Multicenter Studies as Topic
This is a "connection" page, showing publications Rudolph Navari has written about Multicenter Studies as Topic.
Connection Strength
0.184
-
Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysis. Future Oncol. 2021 Aug; 17(23):3027-3035.
Score: 0.184